Lippo Karawaci Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Lippo Karawaci Tbk. trades at Rp63 (market cap 4.25T, 148.64M 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp258 (market cap 678.4B, 25.57M 24h volume). The key difference: Lippo Karawaci Tbk. is far larger — about 6.3× Charlie Hospital Semarang Tbk.'s market cap, and Lippo Karawaci Tbk. is more actively traded (148.64M versus 25.57M). Which is the better fit depends on your goals.
| LPKR | RSCH | |
|---|---|---|
Market Cap | 4.25T | 678.4B |
Volume | 148.64M | 25.57M |
Lot | 1.49M | 255.67K |
Turnover | 9.21B | 6.57B |
Average Price | 61.95 | 256.8 |
Value | 9.21B | 6.57B |
Indicative Equilibrium Price | 63 | 258 |
Indicative Equilibrium Volume | 18.08K | 110 |
Trailing returns across standard periods
Latest headlines on both assets
PT Lippo Karawaci Tbk was established under the name of PT Tunggal Reksakencana on October, 1990. The Company's scope of activities includes real estate, urban development and infrastructure, industrial estate development, general facilities and infrastructure development, services and investments, both direct and indirect, either through its subsidiaries or in joint venture with other parties.
Read more on LPKR →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →